Neuralink

As of Oct 29, 2026, Neuralink's estimated valuation is $48.45B; its last round was a Series E on Jun 2, 2025, raising $486.75M at a $9.64B valuation. Pre-IPO exposure trades as perpetual futures on Gate and as tokens from PreStocks.

Neuralink

Neurotechnology

Estimated Valuation$48.45B

Valuation As OfOct 29, 2026

Latest Raise$486.75M

Latest RoundSeries E

Latest Funding Valuation$9.64B

Latest Funding DateJun 2, 2025

Loading chart...

About Neuralink

Neuralink is Elon Musk's brain-computer interface company developing implantable chips that connect the human brain to computers, aimed at helping people with paralysis and eventually enabling broader human-AI interaction.

Funding rounds

Round
Jun 2, 2025Series E$486.75M$9.64B
Aug 7, 2023Series D$323.2M$3.49B
Jul 29, 2021Series C$205M$2.15B
May 10, 2019Series B-1$156,279$575.09M
Apr 29, 2019Series B$51M-
Aug 25, 2017Series A$107M$142.67M

Perpetual markets

ExchangeTypeContract
GateCEXgate:NEURALINK_USDT$446.61$1,932$8,780.350%$446.61B

Token issuers

IssuerBacking
PreStocksSPV interest$404.0017$1.05M-

Frequently asked questions

What is Neuralink's estimated valuation?

As of Oct 29, 2026, Neuralink's latest tracked valuation estimate is $48.45B.

When was Neuralink's last funding round?

Neuralink's latest tracked funding round was a Series E on Jun 2, 2025, raising $486.75M at a $9.64B valuation.

Where can I get pre-IPO exposure to Neuralink?

As of Oct 30, 2026, Neuralink pre-IPO exposure trades as perpetual futures on Gate and as tokens from PreStocks.

Valuation and funding data updated Oct 30, 2026, 1:56 AM UTC.

Market data updated Oct 30, 2026, 1:56 AM UTC.